CoChat

Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research

Open access
Lackland, Daniel T., Carey, Robert M., Conforto, Adriana B., Rosendorff, Clive, Whelton, Paul K., Gorelick, Philip B. · 2018 · Stroke
Cited by 43

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The decline in stroke mortality observed over the past 50 years has been attributed, in part, to improved implementation of high blood pressure (BP) treatment and control strategies based on the most current evidence from clinical research studies and randomized controlled trials (RCTs).1 The reduction in stroke risks coincides with the shift to lower systolic BP (SBP) distributions in the US adult population for all age groups.1 However, critical clinical questions remain about the treatment, control, and prevention of high BP. New evidence from RCTs and meta-analyses2–6 is expected to have an important positive impact on hypertension guidelines, clinical practice, and future research. Because stroke risk is substantially associated with BP levels and hypertension treatment and control, raised BP and stroke reduction is so heavily tied to BP control, stroke prevention is a key driving force for clinical practice decisions. As a component of the 2017 International Stroke Conference, the American Heart Association, American Stroke Association, and World Hypertension League cosponsored session focused on impact of recent hypertension studies, meta-analyses and new clinical guidelines on stroke risk reduction, and implications for future research. The Prospective Studies Collaboration7 showed a log-linear relationship between BP and stroke declining with lower BP values right down to <120 mm Hg systolic and <70 mm Hg diastolic. Further, a meta-analysis of 147 RCTs of antihypertensive therapy the percentage reduction in stroke with BP reduction down to a mean of 110/70 mm Hg regardless of their BP before treatment.8 Another systematic review in patients with diabetes mellitus reported a decrease of 13% in the risk of stroke for each 5 mm Hg reduction in SBP, and by 11.5% for each 2 mm Hg reduction in diastolic BP.9 In another meta-analysis of 123 studies, Ettehad et al4 provided support for lowering SBP to …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.117.019379

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 43

Metadata

Authors
Lackland, D. T., Carey, R. M., Conforto, A. B., Rosendorff, C., Whelton, P. K., & Gorelick, P. B.
Venue
Stroke
Published
2018-03
Volume
49
Issue
3
Pages
772-779
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2794331012
Cited by
43
References
19
FWCI
2.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research. https://app.cochat.ai/papers/10.1161/strokeaha.117.019379
The paper
Lackland, D. T., Carey, R. M., Conforto, A. B., Rosendorff, C., Whelton, P. K., & Gorelick, P. B. (2018). Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research. Stroke. https://doi.org/10.1161/strokeaha.117.019379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.